| Trial ID: | L4801 |
| Source ID: | NCT04507438
|
| Associated Drug: |
Donepezil 5-10 Mg Oral Tablet
|
| Title: |
The Effect of Donepezil on Glycemic Control in Type II Diabetics
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Donepezil 5-10 Mg Oral Tablet|DRUG: Placebo Oral Tablet
|
| Outcome Measures: |
Primary: Change in Hemoglobin A1C, 8 weeks | Secondary: Change in blood urea nitrogen, Change will be assessed by reviewing blood urea nitrogen/creatinine, 8 Weeks|Change in creatinine, Change will be assessed by reviewing blood urea nitrogen/creatinine, 8 weeks | Other: Change in lipid profile, 8 Weeks|Change in albumin, Weight and albumin will be monitored to asses change in nutritional status, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
7
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2019-07-12
|
| Completion Date: |
2023-09-12
|
| Results First Posted: |
|
| Last Update Posted: |
2023-10-13
|
| Locations: |
University of Maryland Shore Regional Health, Easton, Maryland, 21601, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT04507438
|
